Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Cancer ; 51(13): 1780-93, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26072362

ABSTRACT

INTRODUCTION: In patients with primary cutaneous melanoma, there is generally a delay between excisional biopsy of the primary tumour and sentinel-node biopsy. The objective of this study is to analyse the prognostic implications of this delay. PATIENTS AND METHOD: This was an observational, retrospective, cohort study in four tertiary referral hospitals. A total of 1963 patients were included. The factor of interest was the interval between the date of the excisional biopsy of the primary melanoma and the date of the sentinel-node biopsy (delay time) in the prognosis. The primary outcome was melanoma-specific survival and disease-free survival. RESULTS: A delay time of 40 days or less (hazard ratio (HR), 1.7; confidence interval (CI), 1.2-2.5) increased Breslow thickness (Breslow ⩾ 2 mm, HR, > 3.7; CI, 1.4-10.7), ulceration (HR, 1.6; CI, 1.1-2.3), sentinel-node metastasis (HR, 2.9; CI, 1.9-4.2), and primary melanoma localised in the head or neck were independently associated with worse melanoma-specific survival (all P < 0.03). The stratified analysis showed that the effect of delay time was at the expense of the patients with a negative sentinel-node biopsy and without regression. CONCLUSION: Early sentinel-node biopsy is associated with worse survival in patients with cutaneous melanoma.


Subject(s)
Lymph Nodes/pathology , Melanoma/secondary , Sentinel Lymph Node Biopsy , Skin Neoplasms/pathology , Waiting Lists , Adult , Aged , Disease-Free Survival , Female , France , History, Ancient , Humans , Kaplan-Meier Estimate , Lymphatic Metastasis , Male , Melanoma/mortality , Melanoma/therapy , Middle Aged , Predictive Value of Tests , Proportional Hazards Models , Retrospective Studies , Risk Factors , Skin Neoplasms/mortality , Skin Neoplasms/therapy , Spain , Tertiary Care Centers , Time Factors , Treatment Outcome
2.
Dermatol Surg ; 28(5): 402-4, 2002 May.
Article in English | MEDLINE | ID: mdl-12030872

ABSTRACT

BACKGROUND: Intense pulsed light (IPL) is an effective and safe method of hair removal. OBJECTIVE: To evaluate the clinical response of hairy grafts and flaps of different anatomic areas to an IPL source. METHODS: Four patients (three men, one woman; 17-72 years old) with hairy skin grafts (n = 2) or flaps (n = 2) were included. Donor skin areas included the forehead (n = 1), supraclavicular (n = 1), abdomen (n = 1), and groin (n = 1). Excisional surgery was performed because of basal cell carcinoma (BCC) of the nasal wall (n = 1), squamous cell carcinoma (SCC) of the forehead (n = 1), congenital nevus of the malar region (n = 1), and breast carcinoma (n = 1). The treatment was IPL with the following parameters: wavelength 695-755 nm, pulse width 3.8-4.5 msec, delay 20-30 msec, spot size 10 mm x 45 mm, fluence 38-42 J/cm2, and an interval of 4 weeks. A total of one to six treatment sessions were administered. RESULTS: A progressive decrease in terminal hair and delayed hair growth rate (more than 8 months) were observed in all the patients. Improvement of skin coarseness, pigmentation, and erythema was also observed in the graft and its periphery in one patient. Persistent erythema (more than 48 hours) was the only side effect, observed in one patient. CONCLUSION: IPL is an effective method to depilate hairy grafts and flaps.


Subject(s)
Hair Removal/methods , Phototherapy/methods , Plastic Surgery Procedures , Surgical Flaps , Adolescent , Adult , Aged , Female , Humans , Lasers , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...